Response to Concerns and Insights on Timing of Immunotherapy and Radiotherapy in Head and Neck Cancer

Documenti analoghi

• Concerns and Insights on Timing of Immunotherapy and Radiotherapy in Head and Neck Cancer: A Response to Janopaul‐Naylor Et Al.
  di: Yusuf Ilhan, et al.
  Pubblicazione: (2024)
• Hypofractionated Accelerated Radiotherapy for Head and Neck Cancer in Fragile Patients
  di: Segado‐Guillot Salvador, et al.
  Pubblicazione: (2024)
• Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review
  di: Lilah Kahloon, et al.
  Pubblicazione: (2026)
• External Validation of Pre‐Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy
  di: Gabriel Adrian, et al.
  Pubblicazione: (2026)
• Exploratory Research: Patient‐Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer
  di: Alice Vergauwen, et al.
  Pubblicazione: (2025)